ReviewThe Kaohsiung journal of medical sciences2022
Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: A narrative review.
Review in The Kaohsiung journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Epithelioid angiomyolipoma: a rare renal tumor with histopathological complexity.Journal of surgical case reports · 2026Article
- Durable Disease Control With Nivolumab in Malignant Epithelioid Angiomyolipoma: A Case Report.IJU case reports · 2026Article
- Renal sclerosing AML/PEComa in a male - A case report and literature review.Urology case reports · 2026Article
- Sporadic Pediatric Renal Epithelioid Angiomyolipoma Mimicking Wilms Tumor: A Case Report and Literature Review.Clinical medicine insights. Case reports · 2026Article
- Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma.Neoplasia (New York, N.Y.) · 2025Article
- Imaging characteristics of renal epithelioid angiomyolipoma and its correlation with risk stratification.Scientific reports · 2025Article
- Spontaneous rupture and hemorrhage of renal epithelioid angiomyolipoma misdiagnosed to renal carcinoma: a case report.Journal of medical case reports · 2024Article
- Renal Angiomyolipoma with Tumor Thrombus in the Inferior Vena Cava and Right Atrium Accompanied by Renal Cell Carcinoma: A Case Report.Medicina (Kaunas, Lithuania) · 2024Article
- Recurrent epithelioid angiomyolipoma of the adrenal gland: a case report and literature review.AME case reports · 2024Article
- Primary renal malignant epithelioid angiomyolipoma with distant metastasis: a case report and literature review.Frontiers in oncology · 2023Article
- Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: A narrative review.The Kaohsiung journal of medical sciences · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal epithelioid angiomyolipoma (EAML) is a unique subtype of angiomyolipoma that contains a variety of cytoplasmic-rich, eosinophilic cytoplasm epithelioid cells in addition to mature adipocytes, hyaline thick-walled vessels, and smooth muscle-like spindle cells. In recent years, increasing evidence has shown that EAML is a potentially malignant tumor. Due to the lack of typical clinical manifestations and imaging features, it is difficult to diagnose before surgery, and the diagnosis mainly depends on postoperative histopathological examination. With the advancement of pathological diagnostic techniques, more EAML cases has been discovered, but clinicians still lack a comprehensive understanding of EAML. This review comprehensively describes some pathological and clinical features of EAML, with special attention to the pathogenesis and treatment of malignant EAML in order to assist with clinical diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.